2.07
price down icon5.05%   -0.11
pre-market  Pre-mercato:  2.05   -0.02   -0.97%
loading

Mustang Bio Inc Borsa (MBIO) Ultime notizie

pulisher
03:18 AM

What drives Mustang Bio Inc. stock priceExtraordinary profit generation - jammulinksnews.com

03:18 AM
pulisher
Jul 21, 2025

What analysts say about Mustang Bio Inc. stockBreakneck growth rates - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Mustang Bio Inc. Stock Analysis and ForecastPhenomenal investment performance - Autocar Professional

Jul 21, 2025
pulisher
Jul 19, 2025

Is Mustang Bio Inc. a good long term investmentBreakthrough wealth creation - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Mustang Bio (NASDAQ:MBIO) Upgraded to “Hold” at Wall Street Zen - Defense World

Jul 19, 2025
pulisher
Jul 15, 2025

How Mustang Bio Inc. stock performs during market volatility200 Percent Gain Alert - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Mustang Bio Inc. stock attracts strong analyst attentionSafe Entry High Exit Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Mustang Bio Inc. stock price move sharplyTriple Digit Return Forecasts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

MBIO Stock: Exploring Mustang Bio Inc’s Growth - investchronicle.com

Jul 15, 2025
pulisher
Jul 09, 2025

Mustang Bio Shares Skyrocket After Orphan Drug Designation - StocksToTrade

Jul 09, 2025
pulisher
Jul 09, 2025

Mustang Bio’s Shares Skyrocket as FDA Grants Orphan Drug Designation - timothysykes.com

Jul 09, 2025
pulisher
Jul 09, 2025

Promising Small Cap Stocks Worth Watching – July 7th - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Top Penny Stocks To Follow Now – July 7th - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Mustang Bio’s Meteoric Surge: What’s Driving Up MBIO? - StocksToTrade

Jul 09, 2025
pulisher
Jul 09, 2025

Mustang Bio’s Stock Soars: What’s Driving the Surge? - timothysykes.com

Jul 09, 2025
pulisher
Jul 09, 2025

Mustang Bio Receives FDA Orphan Drug Designation - TipRanks

Jul 09, 2025
pulisher
Jul 09, 2025

Best Medical Stocks To Follow Today – July 7th - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Promising Pharmaceutical Stocks To Consider – July 7th - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Top Biotech Stocks To Research – July 7th - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Calidi Biotherapeutics Stock Jumps 39% After Hours — What's Going On - Benzinga

Jul 09, 2025
pulisher
Jul 08, 2025

MBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy - TradingView

Jul 08, 2025
pulisher
Jul 08, 2025

Mustang Bio Stock Jumps 180% After FDA Grants Orphan Drug Status to Brain Cancer Drug - inkl

Jul 08, 2025
pulisher
Jul 08, 2025

Why Did Mustang Bio Plunge 11.68% After 196.21% Surge? - AInvest

Jul 08, 2025
pulisher
Jul 07, 2025

Market Wrap | US Stocks Slide as Fed Rate Cut Hints Emerge Palantir and Mustang Bio Soar - AInvest

Jul 07, 2025
pulisher
Jul 07, 2025

Mustang Bio (MBIO) Stock Explodes 260% After FDA Grants Key Cancer Drug Designation - Benzinga

Jul 07, 2025
pulisher
Jul 07, 2025

Dow Dips 1%; Mustang Bio Shares Spike Higher - inkl

Jul 07, 2025
pulisher
Jul 07, 2025

Biotech Stock Analysis: MBIO Soars after FDA Grants Orphan Drug Designation - Markets.com

Jul 07, 2025
pulisher
Jul 07, 2025

This BlackRock stock just spiked over 300% - Finbold

Jul 07, 2025
pulisher
Jul 07, 2025

Mustang Bio Stock Surges: Time to Reconsider? - StocksToTrade

Jul 07, 2025
pulisher
Jul 07, 2025

FDA grants orphan drug status to Mustang Bio’s glioma treatment By Investing.com - Investing.com Canada

Jul 07, 2025
pulisher
Jul 07, 2025

Mustang Bio’s Drastic Turn: Opportunity or Red Flag? - timothysykes.com

Jul 07, 2025
pulisher
Jul 07, 2025

Mustang Bio rises after FDA orphan drug status for MB-101 - Seeking Alpha

Jul 07, 2025
pulisher
Jul 07, 2025

Mustang Bio stock soars after FDA grants orphan drug designation By Investing.com - Investing.com South Africa

Jul 07, 2025
pulisher
Jul 07, 2025

Mustang Bio stock soars after FDA grants orphan drug designation - Investing.com

Jul 07, 2025
pulisher
Jul 07, 2025

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma - The Manila Times

Jul 07, 2025
pulisher
Jul 07, 2025

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for - GlobeNewswire

Jul 07, 2025
pulisher
Jul 07, 2025

Breakthrough Brain Cancer Treatment: FDA Backs Mustang Bio Therapy After 66-Month Complete Response in Trials - Stock Titan

Jul 07, 2025
pulisher
Jul 02, 2025

Mustang Bio Plunges 25.37% Amid Reverse Split, Financial Woes - AInvest

Jul 02, 2025
pulisher
Jun 17, 2025

Mustang Bio (NASDAQ:MBIO) Shares Down 5.1% – What’s Next? - Defense World

Jun 17, 2025
pulisher
Jun 06, 2025

ASCO: Kite’s Glioblastoma CAR-T Highlights Solid Tumor Progress - insights.citeline.com

Jun 06, 2025
pulisher
Jun 05, 2025

Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews

Jun 05, 2025
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
Capitalizzazione:     |  Volume (24 ore):